Meeting
2020 Genitourinary Cancers Symposium
Nephrectomy after complete response to immune checkpoint inhibitors for metastatic renal cell carcinoma (mRCC): A new surgical challenge?
Authors
Geraldine Pignot
Department of Surgical Oncology, Institut Paoli-Calmettes, Marseille, France
Geraldine Pignot , Antoine Thiery-Vuillemin , Jochen Walz , Herve Lang , Pierre Werle , Loic Balssa , Lionnel Geoffrois , Louis Leblanc , Laurence Albiges , Vincenzo Di Nunno , Karim Bensalah , Sylvain Ladoire , Gwenaelle Gravis , Philippe Barthelemy
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer
Track
Renal Cell Cancer
Sub Track
Therapeutics
Citation
J Clin Oncol 38, 2020 (suppl 6; abstr 707)
Abstract #
707
Poster Bd #
H5
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Implications of ethnicity among patients with metastatic renal cell carcinoma (mRCC) treated with nivolumab plus ipilimumab (nivo/ipi).
First Author: Sally Leong
Poster
2021 ASCO Annual Meeting
Outcomes of first-line (1L) ipilimumab and nivolumab (IPI-NIVO) and subsequent therapy in metastatic renal cell carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC).
First Author: Chun Loo Gan
Poster
2021 Genitourinary Cancers Symposium
Treatment response in the intact primary renal mass (P-Rmass) and its relationship to the overall response to treatment in patients with metastatic renal cell carcinoma (mRCC).
First Author: Hamid Emamekhoo
Poster
2018 Genitourinary Cancers Symposium
Tivozanib combined with nivolumab: Phase Ib/II study in metastatic renal cell carcinoma (mRCC).
First Author: Bernard Escudier